Results 41 to 50 of about 13,228,211 (287)

The factors predicting early extubation after targeted temperature management for out of hospital cardiac arrest patients [PDF]

, 2018
St.
Tanaka, Hiroyuki
core   +1 more source

Impact of protocolized postarrest care with targeted temperature management on the outcomes of cardiac arrest survivors without temperature management

Annals of Medicine, 2022
Introduction Protocolized postarrest care that includes targeted temperature management (TTM) improves survival and neurological outcomes in cardiac arrest survivors.
Dean-An Ling, Chien-Hua Huang, Wen-Jone Chen, Po-Ya Chuang, Wei-Tien Chang, Chih-Wei Sung, Wei-Ting Chen, Hooi-Nee Ong, Min-Shan Tsai   +8 more
doaj   +1 more source

Identifying Risk Factors for Prolonged Length of Stay in Hospital and Developing Prediction Models for Patients with Cardiac Arrest Receiving Targeted Temperature Management

Reviews in Cardiovascular Medicine, 2023
Background: Prolonged length of stay (LOS) following targeted temperature management (TTM) administered after cardiac arrest may affect healthcare plans and expenditures.
Wei-Ting Chiu, Lung Chan, Jakir Hossain Bhuiyan Masud, Chien-Tai Hong, Yu-San Chien, Chih-Hsin Hsu, Cheng-Hsueh Wu, Chen-Hsu Wang, Shennie Tan, Chen-Chih Chung   +9 more
doaj   +1 more source

Bleeding complications after cardiac arrest and targeted temperature management, a post hoc study of the targeted temperature management trial

, 2019
Target Temperature Management (TTM) is standard care following out of hospital cardiac arrest (OHCA). The aim of the study was to evaluate if treatment temperature (33°C or 36°C) or other predefined variables were associated with the occurrence of ...
Dankiewicz, Josef,, Schött, Ulf,, Kander, Thomas,, Ullén, Susann,, Rundgren, Malin,, Lund University., Wise, MP,   +6 more
core   +1 more source

Targeted Temperature Management During the Summer Months

Therapeutic Hypothermia and Temperature Management, 2018
W. Dalton Dietrich, Dietrich, W. Dalton
core   +3 more sources

A Study on the Outcome of Targeted Temperature Management Comparing Cardiac Arrest Patients Who Received Bystander Cardiopulmonary Resuscitation With Those Who Did Not, Using the Nationwide TIMECARD Multicenter Registry

Frontiers in Medicine, 2022
Background and PurposeTargeted temperature management (TTM) is associated with decreased mortality and improved neurological function after cardiac arrest.
Fang-Yu Liou, Fang-Yu Liou, Min-Shan Tsai, Li-Kuo Kuo, Li-Kuo Kuo, Hsin-Hui Hsu, Chih-Hung Lai, Chih-Hung Lai, Kun-Chang Lin, Wei-Chun Huang, Wei-Chun Huang, Wei-Chun Huang   +11 more
doaj   +1 more source

Efficacy of Quantitative Pupillary Light Reflex for Predicting Neurological Outcomes in Patients Treated with Targeted Temperature Management after Cardiac Arrest: A Systematic Review and Meta-Analysis

Medicina, 2022
Background and objectives: This study aims to evaluate the usefulness of the quantitative pupillary light reflex as a prognostic tool for neurological outcomes in post-cardiac arrest patients treated with targeted temperature management (TTM).
Jae-Guk Kim, Hyungoo Shin, Tae-Ho Lim, Wonhee Kim, Youngsuk Cho, Bo-Hyoung Jang, Kyu-Sun Choi, Min-Kyun Na, Chiwon Ahn, Juncheol Lee   +9 more
doaj   +1 more source

Temperature control in adults after cardiac arrest: a survey of current clinical practice in Germany

Critical Care, 2023
Background Temperature control is recommended after out of hospital cardiac arrest (OHCA) by international guidelines. This survey aimed to investigate current clinical practice and areas of uncertainty.
Kevin Roedl, Sebastian Wolfrum, Guido Michels, Martin Pin, Gerold Söffker, Uwe Janssens, Stefan Kluge   +6 more
doaj   +1 more source

Targeted support for high growth firms : theoretical constraints, unintended consequences and future policy challenges [PDF]

, 2015
The authors wish to thank Scottish Enterprise and the OECD for funding the research reported in this paper.High growth firms are now a major focus within enterprise policy.
Brown, Ross Crawford, Mawson, Suzanne, Brown, Ross   +2 more
core   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source